Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 55, pseudogene (RN7SL55P) is a human pseudogene that resembles the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP)[5][7]. Pseudogenes are segments of DNA that look like functional genes but typically do not encode functional products and are considered noncoding and nonfunctional[5][7]. 7SL RNA plays an essential role in the SRP complex, facilitating protein targeting to the endoplasmic reticulum, but the pseudogenes such as RN7SL55P generally do not participate in this process[8][4]. Some pseudogenes can generate non-coding RNAs that might have regulatory effects, such as acting as miRNA sponges, but there is no evidence suggesting RN7SL55P itself serves as a therapeutic target, encodes a protein, or directly influences disease states[2][5]. RN7SL55P is not a receptor, enzyme, transporter, or classical drug target[7][5]. There is no evidence that it interacts with drugs, is targeted for therapeutic purposes, or serves as a biomarker or safety concern. The entry here is likely a nonfunctional, transcribed pseudogene; thus, listing it as a therapeutic or molecular drug target is incorrect[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 55, pseudogene (RN7SL55P).